Want to join the conversation?
$VRTX's revenues increased significantly in 2015 as compared to 2014, primarily due to cystic fibrosis treating drug Orkambi net product revenues, which commenced in 3Q15, and a $167.9MM increase in Kalydeco net product revenues, partially offset by a $43.6MM decrease in its collaborative revenues.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!